| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Neervannan Seshadri is a Chief Operating Officer at TARS. Recent filings cover 0 purchases and 11 sales. Those positions are worth an estimated $6.7M at current prices.
Our model assigns Neervannan Seshadri a below-average insider score of 36/100, based on 10 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -76.3%.
Neervannan Seshadri's largest disclosed position is in TARS as Chief Operating Officer, worth about $6.7M. The recent filings there lean toward selling, a net 19,264 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 4,564 | $85.00 | $387,940.00 | -5.5% | - | - | |
| Mar 20, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 7,583 | $47.89 | $363,141.50 | -8.7% | -17.7% | +29.3% | |
| Mar 18, 2024 | TARS Tarsus Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 4,879 | $30.60 | $149,297.40 | -7.0% | -5.8% | +50.8% | |
| Mar 23, 2023 | TARS Tarsus Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 1,141 | $12.55 | $14,324.14 | -2.0% | +51.2% | +176.9% | |
| Mar 20, 2023 | TARS Tarsus Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 740 | $12.94 | $9,572.60 | -1.3% | +46.1% | +141.5% | |
| Mar 16, 2023 | TARS Tarsus Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 357 | $13.43 | $4,794.51 | -0.6% | +38.5% | +135.3% |